September 6, 2024- Half a million fewer U.S. youth reported current use of e-cigarettes in 2024 compared to 2023, according to new data from the National Youth Tobacco Survey (NYTS) released today by the U.S. Food and Drug Administration and the U.S. Centers for Disease Control and Prevention. The nationally representative data featured in Morbidity and Mortality Weekly … [Read more...]

September 5, 2024- A team of Mayo Clinic researchers has developed an innovative computational tool that analyzes the gut microbiome, a complex ecosystem of trillions of bacteria, fungi, viruses and other microorganisms within the digestive system, to provide insights into overall well-being. In a new study published in Nature Communications, the tool demonstrated … [Read more...]

September 5, 2024- Frost & Sullivan recently researched and conducted a review of the global healthcare supplies industry and based on its findings, recognizes Ansell with the 2024 Global Company of the Year Award. Ansell is a global leader in protection solutions, specializing in safety products, such as gloves and personal protective equipment (PPE), to protect workers in … [Read more...]

September 5, 2024- A new national survey by Cleveland Clinic revealed similarities and differences across generations when it comes to men’s health. The survey highlights health priorities and concerns among men; however, there were generational differences in health habits, mental health and the use of social media as a source of health information. While 95% of men … [Read more...]

September 5, 2024- Access Vascular, Inc. (AVI), a leader in tackling critical vascular access challenges with its advanced hydrophilic biomaterial technology, announced a strategic partnership with Capstone Health Alliance, a prominent regional group purchasing organization (GPO). This collaboration will extend access to Access Vascular's cuttingedge MIMIX® hydrophilic … [Read more...]

September 5, 2024- Abbott announced it has initiated a clinical trial, called the TRANSCEND study, to evaluate the use of the company's deep brain stimulation (DBS) system to manage treatment-resistant depression (TRD), a form of major depressive disorder. The U.S. Food and Drug Administration (FDA) granted Abbott Breakthrough Device designation to explore use of DBS … [Read more...]

September 4, 2024- Respiratory season is almost upon us, and with it, tests, doctor visits and vaccines. Though the targeted strains of flu vaccine change every year, the way those vaccines are produced and sold do not. But that might be changing. Every respiratory season has the public health community atwitter about eggs. That’s because the most common method used to … [Read more...]

September 4, 2024- Premier submitted comments on the calendar year (CY) 2025 Physician Fee Schedule (PFS) proposed rule. In our detailed comments, Premier urged CMS to: Learn More … [Read more...]

September 4, 2024- The US Oncology Network (The Network) announced today that Illinois CancerCare (ILCC) has joined The Network, effective Sept. 1, 2024. The Network is supported by McKesson Corporation. The practice is the predominant oncology provider throughout central Illinois. By adding ILCC to The Network, the organization continues its ongoing growth … [Read more...]

September 4, 2024-  Humana Inc. announced a new value-based kidney care program with Evergreen Nephrology, designed to advance quality of care and help optimize health outcomes for people living with chronic kidney disease and end-stage kidney disease. Humana Medicare Advantage members who qualify for the program will now have access to a team of Evergreen professionals who … [Read more...]